In this episode, we hear from Nate Beyor, managing director and partner of BCG healthcare. We dive into many topics around digital therapeutics and get a bird's eye view across BCG's customer base.
In this episode, we cover:
New company creation: large company spin-outs vs entrepreneurs
What it takes to build a team that can take a digital therapeutic to market
Why build rather than buy a new DTx
Approaching medical pharma clients vs approaching smaller DTx companies
Go to market strategy and value creation: Standalone vs Drug+
Embedding clinical decision support into workflows
Guest Links and Resources:
Connect with Nate Beyor on: LinkedIn
Visit: www.bcg.com/
Host Links:
Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App
HealthXL: Website | Twitter | Join an Event
Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:
> Presenting Partner: Amalgam Rx
> Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health
Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram
Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram
Ep40: Taking DTx to Market: Nate Beyor Gives Insights On Building Teams and Products